News | July 13, 2022
Eversana partners with Compai Pharma to expand commercialisation services across APAC
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
The appointments will add to the well-diversified experience that currently exists on the PPL board.
LifeWell Raises USD 80M from OrbiMed to Build Large Scale Healthcare Delivery Platform with Full stack Diagnostics~
The combined company will be able to better serve both our global and regional customers with local production
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Subscribe To Our Newsletter & Stay Updated
